Financials data is unavailable for this security.
View more
Year on year S2Medical AB (publ) grew revenues 49.27% from 4.67m to 6.97m while net income improved from a loss of 29.46m to a smaller loss of 22.71m.
Gross margin | 89.45% |
---|---|
Net profit margin | -17.62% |
Operating margin | 20.76% |
Return on assets | -5.91% |
---|---|
Return on equity | -14.21% |
Return on investment | -14.21% |
More ▼
Cash flow in SEKView more
In 2023, cash reserves at S2Medical AB (publ) fell by 2.21m. Cash Flow from Financing totalled 15.47m or 221.90% of revenues. In addition the company used 16.52m for operations while cash used for investing totalled 1.15m.
Cash flow per share | -0.0013 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.0273 |
---|---|
Tangible book value per share | -0.005 |
More ▼
Balance sheet in SEKView more
Current ratio | 0.6751 |
---|---|
Quick ratio | 0.4329 |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼